Evidence map›Paper›PMID 38991068›Full record

ArticleScience (New York, N.Y.)2024

Antagonistic conflict between transposon-encoded introns and guide RNAs.

Rimantė Žedaveinytė, Chance Meers, Hoang C Le, Edan E Mortman, Stephen Tang, George D Lampe, Sanjana R Pesari, Diego R Gelsinger, Tanner Wiegand, Samuel H Sternberg

Abstract read
In one paragraph

Article in Science (New York, N.Y.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Rimantė ŽedaveinytėDepartment of Biochemistry and Molecular Biophysics, Columbia University, New York, NY 10032, USA.ORCID 0000-0002-0738-6976
Chance MeersDepartment of Biochemistry and Molecular Biophysics, Columbia University, New York, NY 10032, USA.ORCID 0000-0003-2554-3987
Hoang C LeDepartment of Biochemistry and Molecular Biophysics, Columbia University, New York, NY 10032, USA.
Edan E MortmanDepartment of Genetics and Development, Columbia University, New York, NY 10032, USA.
Stephen TangDepartment of Biochemistry and Molecular Biophysics, Columbia University, New York, NY 10032, USA.ORCID 0000-0001-5492-9796
George D LampeDepartment of Biochemistry and Molecular Biophysics, Columbia University, New York, NY 10032, USA.ORCID 0000-0002-2873-2372
Sanjana R PesariDepartment of Biochemistry and Molecular Biophysics, Columbia University, New York, NY 10032, USA.
Diego R GelsingerDepartment of Biochemistry and Molecular Biophysics, Columbia University, New York, NY 10032, USA.
Tanner WiegandDepartment of Biochemistry and Molecular Biophysics, Columbia University, New York, NY 10032, USA.ORCID 0000-0002-0528-268X
Samuel H SternbergDepartment of Biochemistry and Molecular Biophysics, Columbia University, New York, NY 10032, USA.ORCID 0000-0001-8240-9114

Funding

Center for Genomic Editing and Recording: Development and Application of Next-Generation Genome and Epigenome Editing Methods to Advance the Study and Treatment of Human DiseaseRM1HG009490 · NHGRI · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI Brittany S. Adamson, Martin Joseph Ankrah Aryee · 2017 to 2026
$22.7M
Medical Scientist Training ProgramT32GM145440 · NIGMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI STEVEN L REINER · 2022 to 2026
$7.3M
A high-performance and versatile technology for precision microbiome engineeringR01EB031935 · NIBIB · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Samuel Henry Sternberg, Harris H Wang · 2021 to 2026
$3.3M
Leveraging Programmable Integrases for Human Genome EngineeringDP2HG011650 · NHGRI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI STERNBERG, SAMUEL HENRY · 2020 to 2020
$2.4M
Impact of CRISPR-associated transposons on anti-phage immunity in Vibrio choleraeR21AI168976 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI STERNBERG, SAMUEL HENRY · 2022 to 2023
$446k
Uncovering the molecular function of novel transposon-encoded Cas9 homologsF32GM143924 · NIGMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MEERS, CHANCE · 2022 to 2023
$139k
NHGRI NIH HHS DP2 HG011650NHGRI NIH HHS RM1 HG009490NIAID NIH HHS R21 AI168976NIBIB NIH HHS R01 EB031935NIGMS NIH HHS F32 GM143924NIGMS NIH HHS T32 GM145440
6 · The paper itself

Abstract

TnpB nucleases represent the evolutionary precursors to CRISPR-Cas12 and are widespread in all domains of life. IS605-family TnpB homologs function as programmable RNA-guided homing endonucleases in bacteria, driving transposon maintenance through DNA double-strand break-stimulated homologous recombination. In this work, we uncovered molecular mechanisms of the transposition life cycle of IS607-family elements that, notably, also encode group I introns. We identified specific features for a candidate "IStron" from

Indexed as

Bacterial ProteinsClostridium botulinumCRISPR-Associated ProteinsDNA Transposable ElementsEndodeoxyribonucleasesIntronsRNA, Guide, CRISPR-Cas SystemsCRISPR-Cas SystemsHomologous RecombinationRNA SplicingTransposasesBacterial ProteinsCas12a proteinCRISPR-Associated ProteinsDNA Transposable ElementsEndodeoxyribonucleasesRNA, Guide, CRISPR-Cas SystemsTransposases

Identifiers

PMID38991068
PMCPMC11758368

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.